Mendelian susceptibility to mycobacterial disease

Clinical Genetics

Volumn 79, Issue 1, 2011, Pages 17-22

  Cottle, L E ^a  

^a ROYAL LIVERPOOL UNIVERSITY HOSPITAL   (United Kingdom)

Author keywords

BCG; Interferon ; Interleukin 12; Mycobacteria

Indexed keywords

GAMMA INTERFERON; GAMMA INTERFERON RECEPTOR 1; I KAPPA B KINASE GAMMA; INTERLEUKIN 12; INTERLEUKIN 23; JANUS KINASE 1; JANUS KINASE 2; STAT1 PROTEIN;

ALLELE; ATYPICAL MYCOBACTERIOSIS; BACTERIAL VIRULENCE; CELL PROLIFERATION; GENE MUTATION; GENETIC HETEROGENEITY; GENETIC SUSCEPTIBILITY; HISTIOCYTOSIS X; HUMAN; LISTERIA MONOCYTOGENES; MENDELIAN SUSCEPTIBILITY TO MYCOBACTERIAL DISEASE; MYCOBACTERIUM ABSCESSUS; MYCOBACTERIUM AVIUM; MYCOBACTERIUM BOVIS; MYCOBACTERIUM TUBERCULOSIS; NATURAL KILLER CELL; NONHUMAN; OUTCOME ASSESSMENT; PHAGOCYTE; PHAGOCYTOSIS; PRIORITY JOURNAL; REVIEW; SALMONELLA; SALMONELLOSIS; SIGNAL TRANSDUCTION; T LYMPHOCYTE;

ADOLESCENT; ALLELES; CHILD; CHILD, PRESCHOOL; CYTOKINES; FEMALE; GENETIC PREDISPOSITION TO DISEASE; HUMANS; IMMUNITY, CELLULAR; MALE; MUTATION; MYCOBACTERIUM; MYCOBACTERIUM INFECTIONS; SALMONELLA INFECTIONS;

CORYNEBACTERINEAE; SALMONELLA;

EID: 78649982134     PISSN: 00099163     EISSN: 13990004     Source Type: Journal    
DOI: 10.1111/j.1399-0004.2010.01510.x     Document Type: Review

References (49)

1. Doffinger R, Patel SY, Kumararatne DS. Host genetic factors and mycobacterial infections: lessons from single gene disorders affecting innate and adaptive immunity. Microbes Infect 2006: 8 (4): 1141-1150.
2. Reichenbach J, Rosenzweig S, Döffinger R, Dupuis S, Holland SM, Casanova JL. Mycobacterial diseases in primary immunodeficiencies. Curr Opin Allergy Clin Immunol 2001: 1 (6): 503-511.
3. Casanova JL, Abel L. Genetic dissection of immunity to mycobacteria: the human model. Annu Rev Immunol 2002: 20: 581-620.
4. Mansouri D, Adimi P, Mirsaeidi M et al. Inherited disorders of the IL-12-IFN-gamma axis in patients with disseminated BCG infection. Eur J Pediatr 2005: 164 (12): 753-757.
5. Van De Vosse E, Hoeve MA, Ottenhoff TH. Human genetics of intracellular infectious diseases: molecular and cellular immunity against mycobacteria and salmonellae. Lancet Infect Dis 2004: 4 (12): 739-749.
6. Van De Vosse E, Ottenhoff TH. Human host genetic factors in mycobacterial and Salmonella infection: lessons from single gene disorders in IL-12/IL-23-dependent signaling that affect innate and adaptive immunity. Microbes Infect 2006: 8 (4): 1167-1173.
7. Patel SY, Doffinger R, Barcenas-Morales G, Kumararatne DS. Genetically determined susceptibility to mycobacterial infection. J Clin Pathol 2008: 61: 1006-1012.
8. Gracie JA, Robertson SE, McInnes IB. Interleukin-18. J Leukoc Biol 2003: 73: 213-224.
9. Van De Vosse E, Van Dissel JT, Ottenhoff TH. Genetic deficiencies of innate immune signalling in human infectious disease. Lancet Infect Dis 2009: 9 (11): 688-698.
10. Haverkamp MH, Van Dissel JT, Holland SM. Human host genetic factors in nontuberculous mycobacterial infection: lessons from single gene disorders affecting innate and adaptive immunity and lessons from molecular defects in interferon-gamma-dependent signaling. Microbes Infect 2006: 8 (4): 1157-1166.
11. Oppmann B, Lesley R, Blom B et al. Novel p19 protein engages IL-12p40 to form a cytokine, IL-23, with biological activities similar as well as distinct from IL-12. Immunity 2000: 13 (5): 715-725.
12. Parham C, Chirica M, Timans J et al. A receptor for the heterodimeric cytokine IL-23 is composed of IL-12Rbeta1 and a novel cytokine receptor subunit, IL-23R. J Immunol 2002: 168 (11): 5699-5708.
13. Al-Muhsen S, Casanova JL. The genetic heterogeneity of Mendelian susceptibility to mycobacterial diseases. J Allergy Clin Immunol 2008: 122 (6): 1043-1051.
14. Filipe-Santos O, Bustamante J, Haverkamp MH et al. X-linked susceptibility to mycobacteria is caused by mutations in NEMO impairing CD40-dependent IL-12 production. J Exp Med 2006: 203 (7): 1745-1759.
15. Jouanguy E, Altare F, Lamhamedi S et al. Interferon-gamma-receptor deficiency in an infant with fatal bacille Calmette-Guérin infection. N Engl J Med 1996: 335 (26): 1956-1961.
16. Newport MJ, Huxley CM, Huston S et al. A mutation in the interferon-gamma-receptor gene and susceptibility to mycobacterial infection. N Engl J Med 1996: 335 (26): 1941-1949.
17. Filipe-Santos O, Bustamante J, Chapgier A et al. Inborn errors of IL-12/23- and IFN-gamma-mediated immunity: molecular, cellular, and clinical features. Semin Immunol 2006: 18 (6): 347-361.
18. Jouanguy E, Dupuis S, Pallier A et al. In a novel form of IFN-gamma receptor 1 deficiency, cell surface receptors fail to bind IFN-gamma. J Clin Invest 2000: 105 (10): 1429-1436.
19. Fieschi C, Dupuis S, Picard C, Smith CI, Holland SM, Casanova JL. High levels of interferon gamma in the plasma of children with complete interferon gamma receptor deficiency. Pediatrics 2001: 107 (4): E48.
20. Dorman SE, Picard C, Lammas D et al. Clinical features of dominant and recessive interferon gamma receptor 1 deficiencies. Lancet 2004: 364 (9451): 2113-2121.
21. Roesler J, Horwitz ME, Picard C et al. Hematopoietic stem cell transplantation for complete IFN-gamma receptor 1 deficiency: a multi-institutional survey. J Pediatr 2004: 145 (6): 806-812.
22. Chantrain CF, Bruwier A, Brichard B et al. Successful hematopoietic stem cell transplantation in a child with active disseminated Mycobacterium fortuitum infection and interferon-gamma receptor 1 deficiency. Bone Marrow Transplant 2006: 38 (1): 75-76.
23. Jouanguy E, Lamhamedi-Cherradi S, Altare F et al. Partial interferon-gamma receptor 1 deficiency in a child with tuberculoid bacillus Calmette-Guérin infection and a sibling with clinical tuberculosis. J Clin Invest 1997: 100 (11): 2658-2664.
24. Remiszewski P, Roszkowska-Sliz B, Winek J et al. Disseminated Mycobacterium avium infection in a 20-year-old female with partial recessive IFNgammaR1 deficiency. Respiration 2006: 73 (3): 375-378.
25. Jouanguy E, Lamhamedi-Cherradi S, Lammas D et al. A human IFNGR1 small deletion hotspot associated with dominant susceptibility to mycobacterial infection. Nat Genet 1999: 21 (4): 370-378.
26. Edgar JD, Smyth AE, Pritchard J et al. Interferon-gamma receptor deficiency mimicking Langerhans' cell histiocytosis. J Pediatr 2001: 139 (4): 600-603.
27. Dorman SE, Holland SM. Mutation in the signal-transducing chain of the interferon-gamma receptor and susceptibility to mycobacterial infection. J Clin Invest 1998: 101 (11): 2364-2369.
28. Vogt G, Chapgier A, Yang K et al. Gains of glycosylation comprise an unexpectedly large group of pathogenic mutations. Nat Genet 2005: 37 (7): 692-700.
29. Vogt G, Bustamante J, Chapgier A et al. Complementation of a pathogenic IFNGR2 misfolding mutation with modifiers of N-glycosylation. J Exp Med 2008: 205 (8): 1729-1737.
30. Döffinger R, Jouanguy E, Dupuis S et al. Partial interferon-gamma receptor signaling chain deficiency in a patient with bacille Calmette-Guérin and Mycobacterium abscessus infection. J Infect Dis 2000: 181 (1): 379-384.
31. Rosenzweig SD, Dorman SE, Uzel G et al. A novel mutation in IFN-gamma receptor 2 with dominant negative activity: biological consequences of homozygous and heterozygous states. J Immunol 2004: 173 (6): 4000-4008.
32. Renauld JC. Class II cytokine receptors and their ligands: key antiviral and inflammatory modulators. Nat Rev Immunol 2003: 3 (8): 667-676.
33. Dupuis S, Jouanguy E, Al-Hajjar S et al. Impaired response to interferon-alpha/beta and lethal viral disease in human STAT1 deficiency. Nat Genet 2003: 33 (3): 388-391.
34. Chapgier A, Kong XF, Boisson-Dupuis S et al. A partial form of recessive STAT1 deficiency in humans. J Clin Invest 2009: 119 (6): 1502-1514.
35. Chapgier A, Boisson-Dupuis S, Jouanguy E et al. Novel STAT1 alleles in otherwise healthy patients with mycobacterial disease. PLoS Genet 2006: 2 (8): e131.
36. Dupuis S, Dargemont C, Fieschi C et al. Impairment of mycobacterial but not viral immunity by a germline human STAT1 mutation. Science 2001: 293 (5528): 300-303.
37. Picard C, Fieschi C, Altare F et al. Inherited interleukin-12 deficiency: IL12B genotype and clinical phenotype of 13 patients from six kindreds. Am J Hum Genet 2002: 70 (2): 336-348.
38. Altare F, Lammas D, Revy P et al. Inherited interleukin 12 deficiency in a child with bacille Calmette-Guérin and Salmonella enteritidis disseminated infection. J Clin Invest 1998: 102 (12): 2035-2040.
39. Altare F, Durandy A, Lammas D et al. Impairment of mycobacterial immunity in human interleukin-12 receptor deficiency. Science 1998: 280 (5368): 1432-1435.
40. Fieschi C, Dupuis S, Catherinot E et al. Low penetrance, broad resistance, and favorable outcome of interleukin 12 receptor beta1 deficiency: medical and immunological implications. J Exp Med 2003: 197 (4): 527-535.
41. Fieschi C, Bosticardo M, De Beaucoudrey L et al. A novel form of complete IL-12/IL-23 receptor beta1 deficiency with cell surface-expressed nonfunctional receptors. Blood 2004: 104 (7): 2095-2101.
42. Alcaiïs A, Fieschi C, Abel L, Casanova JL. Tuberculosis in children and adults: two distinct genetic diseases. J Exp Med 2005: 202 (12): 1617-1621.
43. Altare F, Ensser A, Breiman A et al. Interleukin-12 receptor beta1 deficiency in a patient with abdominal tuberculosis. J Infect Dis 2001: 184 (2): 231-236.
44. Caragol I, Raspall M, Fieschi C et al. Clinical tuberculosis in 2 of 3 siblings with interleukin-12 receptor beta1 deficiency. Clin Infect Dis 2003: 37 (2): 302-306.
45. Ozbek N, Fieschi C, Yilmaz BT et al. Interleukin-12 receptor beta 1 chain deficiency in a child with disseminated tuberculosis. Clin Infect Dis 2005: 40 (6): e55-e58.
46. MacLennan C, Fieschi C, Lammas DA et al. Interleukin (IL)-12 and IL-23 are key cytokines for immunity against Salmonella in humans. J Infect Dis 2004: 190 (10): 1755-1757.
47. Minegishi Y, Saito M, Morio T et al. Human tyrosine kinase 2 deficiency reveals its requisite roles in multiple cytokine signals involved in innate and acquired immunity. Immunity 2006: 25 (5): 745-755.
48. Li Q, Verma IM. NF-kappaB regulation in the immune system. Nat Rev Immunol 2002: 2 (10): 725-734.
49. Bustamante J, Picard C, Fieschi C et al. A novel X-linked recessive form of Mendelian susceptibility to mycobacterial disease. J Med Genet 2007: 44 (2): e65.